A cohort of supporting metabolic enzymes is coinduced with nitric oxide synthase in human tumor cell lines

A K Nussler1, Z Z Liu, K Hatakeyama

  • 1Department of General Surgery, University of Ulm, Germany.

Cancer Letters
|May 15, 1996
PubMed

Insights

Human tumor cells can produce nitric oxide (NO) via inducible NO synthase (iNOS). Supporting metabolic pathways are coinduced with iNOS, maximizing NO synthesis and offering potential therapeutic targets.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Cancer Research

Background:

  • Nitric oxide (NO) exhibits dual roles, acting as cytotoxic or cytoprotective agent.
  • Tumor cells can synthesize NO through inducible NO synthase (iNOS).
  • Understanding NO synthesis regulation in tumors is crucial for cancer biology.

Purpose of the Study:

  • To investigate cellular processes regulating NO synthesis by iNOS in human tumor cells.
  • To identify metabolic pathways supporting iNOS activity.

Main Methods:

  • Analysis of iNOS expression in human tumor cell lines.
  • Assessment of argininosuccinate synthetase and GTP-cyclohydrolase-I activity.
  • Evaluation of coinduction patterns with iNOS.

Main Results:

  • iNOS expression was observed in two human tumor cell lines.
  • Argininosuccinate synthetase and GTP-cyclohydrolase-I were coinduced with iNOS.
  • Coinduction of these enzymes maximizes NO synthesis by iNOS.

Conclusions:

  • Coordinated upregulation of metabolic pathways supports maximal NO production in iNOS-expressing tumor cells.
  • These pathways represent potential targets for pharmacological intervention in cancer therapy.